Bearing in mind the multiple functions of mortalin in cell control, is not surprising that over-expression of mortalin is able to promote cancer and may trigger features associated with neurodegenerative diseases, including Parkinson’s and Alzheimer’s diseases. Here, HSPA9 is linked to early-onset autosomal dominant Alzheimer disease.